MKM Partners Sees Amarin's (AMRN) Patents Protecting Vascepa into 2030
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amarin Corp (AMRN) Gets USPTO Notice of Allowance for '889, '153 Apps
September 5, 2012 8:34 AM EDTAmarin Corporation plc (Nasdaq: AMRN) announced that the United States Patent and Trademark Office (USPTO) has published notification of Notices of Allowance for two additional U.S. Patent Applications, Serial Numbers 12/702,889 and 13/349,153. These applications include claims intended to protect the Vascepa (icosapent ethyl) indication approved in July 2012 by the U.S. Food and... More
Jefferies Maintains a 'Buy' on Amarin Corporation (AMRN); What's New At The Patent Website?
September 5, 2012 7:27 AM EDTJefferies maintains a 'Buy' on Amarin Corporation (NASDAQ: AMRN) price target of $28.00.
Analyst, Thomas Wei, said, "On the U.S. Patent and Trademark Office (PTO) website today, notice of allowance data verifications were completed for 153 and 889 MARINE applications, a positive step to strengthening the 2030... More
Amarin (AMRN) '889 Patent Allowed
September 4, 2012 12:52 PM EDTAmarin Corporation plc (NASDAQ: AMRN) is moving higher mid-day after an update on all-important patent 12/702,889 at the USPTO website.
According to the site, 'Notice of Allowance Data Verification Completed' and 'Document Verification' was complete today, 9/4.
This is addition to... More
Amarin Corp. (AMRN) Receives USPTO Notice of Allowance for '145 App
September 4, 2012 8:41 AM EDTAmarin Corporation plc (Nasdaq: AMRN), announced that the United States Patent and Trademark Office (USPTO) has published notification of a Notice of Allowance for U.S. Patent Application Serial Number 13/282,145, titled "Method of Treating Hypertriglyceridemia." The application includes claims intended to protect the Vascepa (icosapent... More
Jefferies Maintains a 'Buy' on Amarin Corporation (AMRN); MARINE Patent Allowed
September 4, 2012 8:06 AM EDTJefferies maintains a 'Buy' on Amarin Corporation (NASDAQ: AMRN) price target of $28.00.
Analyst, Thomas Wei, said, "The patent office (PTO) issued a notice of allowance to the 145 MARINE application. While largely expected, we believe this is an incremental positive for AMRNs strategy to... More
